2 October 2026
Researchers uncover how Ezrin and eIF4E coordinate localized protein translation in AML cells, supporting cell movement and disease progression. The findings reveal a new link between translation machinery and leukemia cell motility.
25 February 2026
Researchers reveal how BOLL-containing protein aggregates regulate mRNA translation during human oogenesis, enhancing the translation of cell cycle regulators and providing new insights into meiotic progression and reproductive biology.
19 January 2026
EZH2 drives prostate cancer progression by regulating m6A RNA modification. By stabilizing FOXA1, EZH2 boosts YTHDF1 expression, enhancing translation of METTL14 and WTAP and increasing global m6A. Targeting this axis suppresses tumor growth.
30 September 2025
Discover how ribosome profiling is transforming translatomics, from its origins and cutting-edge methodologies to advanced bioinformatics and breakthrough applications in cancer, neurodegeneration, infectious diseases, and more.
22 September 2025
Researchers identified METTL5 as a key driver of immune resistance in ovarian cancer. By altering rRNA methylation and ATF4 translation, METTL5 suppresses ferroptosis, reducing response to immunotherapy. Targeting this axis may enhance ICB efficacy.
11 August 2025
Today, ribosomes are emerging as regulatory hubs that actively shape gene expression. Are you ready to uncover their hidden role and explore the technologies driving their discovery?
